Clinical Trial Update: Lifestyle Heart Trial [Phase 2]

View source ↗

Summary

Phase 2 Lifestyle Heart Trial has completed. The study evaluated a lifestyle modification program for coronary artery disease and its ischemic manifestations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Myocardial Ischemia

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Coronary Arteriosclerosis | Phase 2 | Status: COMPLETED